We describe a patient with a subarachnoid hemorrhage that presented with electrocardiographic evidence of transmural myocardial infarction. The patient was found to have normal coronaries and on autopsy revealed generalized myocytolysis with no evidence of transmural myocardial infarction. This case
Hypertensive intracerebral hemorrhage simulating acute myocardial infarction
β Scribed by Sadasiva Rao Katta; William A Berk
- Publisher
- Elsevier Science
- Year
- 1992
- Tongue
- English
- Weight
- 817 KB
- Volume
- 21
- Category
- Article
- ISSN
- 1097-6760
No coin nor oath required. For personal study only.
β¦ Synopsis
The decision to administer thrombolytic therapy for acute myocardial infarction depends on clinical presentation and characteristic ECG findings of acute injury. Inappropriate initiation of thrombolysis may occur when other clinical entities mimic myocardial infarction both clinically and electrocardiographically. We present the case of a 49-year-old woman who presented with cardiovascular collapse and ECG findings strongly suggestive of myocardial infarction. Computed brain tomography eventually revealed right temporal lobe hemorrhage, the apparent cause of the observed ECG abnormalities. ST-segment elevation resolved rapidly, and serial creatine phosphokinase isoenzyme determinations were negative. Because closed-chest cardiac massage had been performed, a thrombolytic agent was not administered. Our experience emphasizes the importance of considering ECG findings in light of clinical presentation and of taking care to consider conditions other than myocardial infarction that may cause ST-segment elevation.
π SIMILAR VOLUMES
The clinical implications of hemorrhagic versus nonhemorrhagic infarcts are currently unclear. Our study suggests that hemorrhage may not simply be a bystander but an active contributor to adverse left-ventricular remodeling following acute myocardial infarction.
We describe two cases of diffuse alveolar hemorrhage and development of ARDS in patients who underwent percutaneous transluminal coronary angioplasty (PTCA) with stenting in whom Abciximab (ReoPro TM ) was used in combination with other agents interfering with the hemostatic mechanism. The developme